Transparency Disclosures | Takeda Pharmaceuticals

Collaborative work between health care professionals and commercial life sciences organizations has long been a positive driver for advancements in patient care and progression of innovative medicine. Takeda’s goal is to reinforce the authentic relationship between pharmaceutical companies and health care professionals, by supporting the principles of transparency and disclosing our annual payments as directed by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and local disclosure codes.

Patient Groups – or patient advocacy groups and patient organizations – are important partners for Takeda. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community. We support patient organizations in our therapeutic areas through sponsorships, grants and donations.

Cybersecurity is crucial for the safety of our products and services as we aim to enhance and protect lives. We actively collaborate with security researchers to identify and address cybersecurity threats, welcoming their participation in our reporting process. Our process supports researchers who disclose vulnerabilities in good faith, aligning with our dedication to security and transparency. Here is how cybersecurity researchers can report vulnerabilities to us voluntarily.